• Explore /
  • Poster
  • / Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma.

Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma.

Abstract Poster

Authors

null

Torben Plesner

Vejle Hospital, Vejle, Denmark

Torben Plesner , Hendrik-Tobias Arkenau , Henk M. Lokhorst , Peter Gimsing , Jakub Krejcik , Charlotte Rose Lemech , Monique Minnema , Ulrik Niels Lassen , Tahamtan Ahmadi , Howard Yeh , Mary Guckert , Nikolai C. Brun , Steen Lisby , Linda Basse , Antonio Palumbo , Paul G. Richardson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Highlights Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Multiple Myeloma

Clinical Trial Registration Number

2011-005709-62

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 8533)

DOI

10.1200/jco.2014.32.15_suppl.8533

Abstract #

8533

Poster Bd #

13

Abstract Disclosures

Similar Posters

First Author: Cyrille Touzeau

First Author: Jonathan L. Kaufman

First Author: Nizar J. Bahlis

First Author: Krish Patel